Skip to content
Recruiting

Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors

About this study

This pilot study will recruit Black/African American prostate cancer survivors into a clinical trial and will randomize each person to 1 of 2 possible treatments - an internet-based treatment for insomnia called Sleep Healthy Using the Internet (SHUTi) or an educational website. SHUTi provides the treatment - cognitive behavioral therapy for insomnia - across 6 lessons, while the educational website is like an online patient brochure. The study will examine the feasibility of SHUTi to improve sleep and well-being among Black prostate cancer survivors. It will also examine whether SHUTi is acceptable to these survivors and will compare the effect of SHUTi versus the educational website on insomnia and non-insomnia patient-reported outcomes.

Condition
Insomnia
Tested
Sleep Healthy Using the Internet (SHUTi), Patient education
Sponsor
Georgetown University

Who can join

Age
21 years and older
Sex
Male only
Healthy volunteers
Not accepted

Inclusion 10

  • Minimum age: 21 years
  • Eligible sex: Male
  • Study condition: Insomnia
  • Age ≥21 years
  • Self-identifies as Black/African American
  • Diagnosed with invasive prostate cancer (AJCC stages I-IV) within 5 years
  • Has not received surgery, chemotherapy, or radiation within the previous 3 months
  • Has a smart phone, tablet, or computer with reliable internet access or willing to attend a weekly study appointment and to complete a weekly phone call
  • Has clinically relevant insomnia symptoms (i.e., score ≥10 on the Insomnia Severity Index)
  • Able to read and understand English

Exclusion 5

  • Employed in an occupation where sleep restriction could be a harm to themselves or others
  • Actively employed in shift work
  • Diagnosed with a severe/major psychiatric disorder
  • Diagnosed with a seizure disorder or recently (≤12 months) experienced a seizure
  • Unable to consent

Where

1 site, 1 recruiting

Georgetown Lombardi Comprehensive Cancer Center

Washington D.C., District of Columbia, United States

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.